Financial Guidance

 
News Articles for Financial Guidance top ^
2014/2/10
THE WOODLANDS, Texas , Feb.
Sign-up for TETRA Technologies, Inc. Announces Estimated Fourth Quarter 2013 Results and 2014 Financial Guidance investment picks
2014/1/13
Natus Medical Incorporated (NASDAQ:BABY) today announced its financial guidance for the first quarter and full year 2014.
Sign-up for Natus Medical Announces 2014 Annual and First Quarter Financial Guidance investment picks
2014/3/10
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that it is revising upward its previously provided 2014 financial guidance for net product sales and non-GAAP earnings per share (EPS). The Company will record increased revenue in 2014 related to an agreement that brings to conclusion discussions with the French government and which positively impacts prospective reimbursement of Soliris.
Sign-up for Alexion Revises Upward 2014 Financial Guidance for Revenues and non-GAAP EPS investment picks
INDIANAPOLIS , Jan.
Sign-up for Lilly Announces 2014 Financial Guidance, Reconfirms 2013 Expectations investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) today announced its anticipated pipeline goals and provided financial guidance for 2014.
Sign-up for Infinity Provides Key 2014 Goals and Financial Guidance investment picks
2013/8/28
Williams-Sonoma, Inc. (NYSE: WSM) today announced operating results for the 13 weeks ended August 4, 2013 (“Q2 13”) versus the 13 weeks ended July 29, 2012 (“Q2 12”). Q2 13 Results Net revenues grew 12.3% to $982 million versus $874 million in Q2 12 with comparable brand revenue growth of 8.4%. Operating margin was 8.0%, equal to Q2 12.
Sign-up for Williams-Sonoma, Inc. Announces Second Quarter 2013 Results Revenues Grow 12%, EPS Increases 14% to $0.49 Raises Financial Guidance for Fiscal Year 2013 investment picks
2013/11/20
Williams-Sonoma, Inc. (NYSE: WSM) today announced operating results for the 13 weeks ended November 3, 2013 (“Q3 13”) versus the 13 weeks ended October 28, 2012 (“Q3 12”). Q3 13 Results Net revenues grew 11.3% to $1.052 billion versus $945 million in Q3 12 with comparable brand revenue growth of 8.2%. Operating margin increased to 8.8% from 8.4% in Q3 12.
Sign-up for Williams-Sonoma, Inc. Announces Third Quarter 2013 Results Revenues Grow 11%, EPS Increases 18% to $0.58 Raises Financial Guidance for Fiscal Year 2013 investment picks
2014/1/14
Stratasys Ltd.
Sign-up for Stratasys Releases Financial Guidance for 2014 investment picks
2013/12/3
HOUSTON, Dec.
Sign-up for LINN Energy Provides Updated Financial Guidance, New Investor Presentation and ISS Recommendation investment picks
2014/1/13
3 Next-Generation Enzyme Replacement Therapies (ERTs) Expected to Enter Clinic in Next 3 Years, Beginning in 2014 FY14 Cash Spend Guidance of $54-$59 Million — Current Cash Expected to Fund Operations Into 2H15 CRANBURY, N.J., Jan.
Sign-up for Amicus Therapeutics Provides Full-Year 2014 Strategic Outlook and Financial Guidance investment picks
2014/1/21
http://media.marketwire.com/attachments/200806/428087_stillwaterlogoresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1083447&ProfileId=051205&sourceType=1 BILLINGS, MT --
Sign-up for Stillwater Mining Company Announces Strategic Priorities and Fiscal Year 2014 Financial Guidance investment picks
2014/3/19
SAExploration Holdings, Inc. (NASDAQ: SAEX, OTCBB: SAEXW) today announced selected unaudited preliminary results for the fourth quarter (“Q4”) and fiscal year ended December 31, 2013 and provided summary financial guidance for fiscal year 2014.
Sign-up for SAExploration Provides Update on Selected Fourth Quarter and Fiscal Year 2013 Results and Fiscal Year 2014 Financial Guidance; Announces Intention to Restate Q2 and Q3 2013 Financials investment picks
2013/12/10
NEW YORK , Dec.
Sign-up for Broadcom Updates Financial Guidance for the Fourth Quarter of 2013 investment picks
2013/12/13
Valeant Pharmaceuticals To Hold Conference Call To Announce 2014 Financial Guidance Canada NewsWire LAVAL, Quebec , Dec.
Sign-up for Valeant Pharmaceuticals To Hold Conference Call To Announce 2014 Financial Guidance investment picks
2014/1/13
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced anticipated development milestones and financial guidance for 2014.
Sign-up for Clovis Oncology Announces 2014 Objectives and Financial Guidance investment picks
2013/12/2
Includes 53 Percent Dividend Increase in 2014; Three-year Financial Forecasts Updated; ONE Gas Announces Net Income and Dividend Growth Guidance TULSA, Okla.
Sign-up for ONEOK Announces Higher 2014 Financial Guidance investment picks
2013/12/2
2014 Net Income and EBITDA Expected to Increase More Than 25 Percent, Driven by Volume Growth from Completed Growth Projects Three-year Financial Forecasts Updated TULSA, Okla.
Sign-up for ONEOK Partners Announces Higher 2014 Financial Guidance investment picks
2013/8/1
Clayton Williams Energy, Inc. (NASDAQ-NMS: CWEI) today filed a Form 8-K with the Securities and Exchange Commission to provide financial guidance disclosures for the year ending December 31, 2013.
Sign-up for Clayton Williams Energy Provides Financial Guidance for 2013 investment picks
2013/9/4
RIDGEFIELD, Conn., Sept.
Sign-up for The Chefs' Warehouse, Inc. Provides Updated 2013 Financial Guidance investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Financial Guidance
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Financial Groups  |  Next: Financial Hardships